CorVel (CRVL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
2025 Annual Meeting scheduled for August 7, 2025, with voting available online or in person.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of six directors to serve until the 2026 annual meeting or until successors are elected.
Ratification of Haskell & White LLP as independent registered public accounting firm for fiscal year ending March 31, 2026.
Approval of the 2025 Stock Incentive Plan.
Board recommends voting in favor of all proposals.
Other business may be considered if properly brought before the meeting.
Board of directors and corporate governance
Six nominees listed for director positions: Michael G. Combs, Joanna C. Burkey, Steven J. Hamerslag, Alan R. Hoops, R. Judd Jessup, and Jeffrey J. Michael.
Latest events from CorVel
- Revenue and EPS rose, with AI-driven efficiency and strong cash supporting growth.CRVL
Q3 20265 Feb 2026 - Technology-driven care management and financial strength position the firm as a top industry innovator.CRVL
Investor presentation3 Feb 2026 - Revenue up 11.3% and EPS up 10% as AI and new accounts drive growth and efficiency.CRVL
Q1 20252 Feb 2026 - Revenue up 13% and EPS up 39% year-over-year, with strong cash and AI-driven efficiency.CRVL
Q3 20259 Jan 2026 - Director elections, auditor ratification, and a new stock plan headline a governance-focused agenda.CRVL
Proxy Filing1 Dec 2025 - Six directors and the external auditor are up for shareholder vote at the August 2024 meeting.CRVL
Proxy Filing1 Dec 2025 - Shareholders will elect six directors and ratify the auditor, with a focus on governance and diversity.CRVL
Proxy Filing1 Dec 2025 - Double-digit revenue and EPS growth, expanded AI operations, and a debt-free balance sheet.CRVL
Q4 202524 Nov 2025 - Revenue up 7% and EPS up 20%, fueled by network solutions, AI, and strong cash flow.CRVL
Q2 20266 Nov 2025